Skip to content
Menu

FibroBiologics, Inc. FBLG

Full chart Compare
Set alert

Price alert · FBLG

All alert types
0.83 USD -0.01 (-1.19%)

Regular-session close

0.83 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

0.8148 Day range 0.888
0.62 52-week range 9.60
YTD
-81.56%
1 year
-87.97%

5D -0.1700 (-16.83%)

0.80000.90001.0000ThuFriMonTueWed0.8400
Market cap
7.46M
EPS (ttm)
-2.51
Shares out
34.66M
Forward P/E
-5.83
YTD return
-81.56%
1-year return
-87.97%
50-day average
2.74
Volume
25.68K
Avg volume
174.21K
Open
0.8148
Previous close
0.84
Day's range
0.8148 – 0.888
52-week range
0.62 – 9.60
Price target
12.75 (+1436.1%)

Key statistics

200-day average
5.70
Enterprise value
71.72M
Price / book
25.93
Free cash flow
-470.00K
Total cash
7.83M
Total debt
1.56M
Return on equity
-267.86%
Short % of float
9.48%

Fundamental scorecard

4 of 25 checks passed on FBLG’s reported financials

ValueGrowthProfitabilityHealthDividend

4of 25 checks passed

  • Value 0 of 5
  • Growth 1 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
FBLG Revenue — quarterly 0
FBLG Net income — quarterly -4.05M
FBLG EPS — quarterly -0.38

Earnings

FBLG recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 2024-0.08-0.080.000.00%
Aug 7, 2024Jun 1, 2024-0.09———
Aug 7, 2024Jun 1, 2024-0.09-0.090.000.00%

Upgrades / downgrades

FBLG analyst upgrades and downgrades
DateFirmActionFromTo
Dec 12, 2024Rodman & Renshawinit—Buy
Nov 20, 2024D. Boral CapitalmainBuyBuy
Nov 13, 2024D. Boral CapitalmainBuyBuy
Nov 13, 2024HC Wainwright & Co.reitBuyBuy
Oct 30, 2024HC Wainwright & Co.init—Buy
Oct 18, 2024EF HuttonmainBuyBuy

About FibroBiologics, Inc.

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on FBLG — it syncs with the Stock Master app.

Insider holders

FBLG insider holders
InsiderRelationLatest transactionDateShares held
KHOJA HAMIDOfficerPurchaseAug 11, 202411,250
O'HEERON PETERChief Executive OfficerStock GiftDec 8, 20245,906,650

Institution ownership

FBLG institution ownership
Holder% heldSharesValueReported
Blackrock Inc.5.07%1,756,5933.69MSep 29, 2024
Vanguard Group Inc2.23%771,4441.62MSep 29, 2024
Geode Capital Management, LLC1.73%599,7601.26MSep 29, 2024
State Street Corporation1.37%475,837999.26KSep 29, 2024
Cascade Financial Partners, LLC 0.87%302,601635.46KSep 29, 2024
Northern Trust Corporation0.61%210,473441.99KSep 29, 2024

Fund ownership

FBLG fund ownership
Holder% heldSharesValueReported
iShares Russell 2000 ETF1.81%627,6761.32MOct 30, 2024
Vanguard Extended Market Index Fund1.18%407,674856.12KSep 29, 2024
Fidelity Small Cap Index Fund0.75%259,500544.95KAug 30, 2024
iShares Russell 2000 Growth ETF0.75%259,295544.52KOct 30, 2024
Vanguard Total Stock Market Index Fund0.44%152,807320.89KSep 29, 2024
Fidelity Extended Market Index Fund0.41%142,802299.88KOct 30, 2024